Document is current
Any future updates will be listed below
-
Authors
Barbara, Giovanni
Aziz, Imran
Ballou, Sarah https://orcid.org/0000-0002-6746-1958
Chang, Lin
Ford, Alexander C. https://orcid.org/0000-0001-6371-4359
Fukudo, Shin https://orcid.org/0000-0003-2265-0349
Nurko, Samuel https://orcid.org/0000-0003-0936-4807
Olano, Carolina https://orcid.org/0000-0002-4340-4051
Saps, Miguel
Sayuk, Gregory
Siah, Kewin T. H. https://orcid.org/0000-0002-2795-5101
Van Oudenhove, Lukas
Simrén, Magnus https://orcid.org/0000-0002-1155-1313
- License Information
-
More Information
Article History
Accepted: 18 December 2024
First Online: 27 January 2025
Competing interests
: G.B., L.C., S.N. and M. Simrén are on the Rome Foundation Board of Directors. G.B. declares consultancies, business interests or sources of honoraria payments from Aboca, AB Biotics, Agave, Alfa Sigma, AGPharma, Bayer, Biocodex, Boehringer, Bromatech, Cadigroup, Danone, Diadema, Falk Pharma, GE Healthcare, Giuliani, Mayoly, Malesci, Sanofi, Sofar and Yakult. L.C. is a consultant for AbbVie, Ardelyx, Atmo, Bausch Health, Food Marble, Ironwood Pharmaceuticals, Trellus Health and Vibrant; and receives grant support from AnX Robotica and Ironwood Pharmaceuticals. L.C. also has stock options in Food Marble, ModifyHealth and Trellus Health. S.N. is a consultant for Abbvie. M. Saps is a consultant for AbbVie and Ironwood, and has received study funding from QOL Medical. G.S. is a speaker and consultant for Sanofi/Regeneron, Salix, Phathom, Ardelyx, Ironwood, AbbVie and GI Health Foundation, and is a Council member of the American Neurogastroenterology and Motility Society. M. Simrén. is a consultant for Danone Nutricia Research, Biocodex, Tillotts, Takeda, Kyowa Kirin, Abbvie, BioGaia, Renapharma and Cinclus Pharma; and has received speaker fees from Tillotts, Kyowa Kirin, Takeda, Biocodex, Sanofi, Abbvie, Janssen Immunology, Pfizer, BioGaia, Renapharma, Mayoly and Bromatech. M. Simrén has also received unrestricted research grants from Genetic Analysis AS and BioGaia. The other authors declare no competing interests.
